Pathology, Dermapathology · Decatur, GA
NPI
1396916219
Since 2008
Specialty
Pathology, Dermapathology
Code 207ZD0900X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1670 Scott Blvd Ste 202
Decatur, GA, 30033
Phone (678) 904-4932
Medicare paid, 2023
$43K
899 services
Medicare patients, 2023
144
Average age 68
Drug cost, 2024
$1.7M
3,122 prescriptions
Company payments, 2025
$4,700
From 17 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Kathleen J Smith was code 99213 (office e&m - established), 122 times for 75 patients. In total Kathleen J Smith billed 899 services in 30 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 122 | 75 | $59.58 | $7,269 |
| 99214 Office E&M - Established | Office | 109 | 64 | $86.74 | $9,454 |
| 17003 Destruction Skin Lesion | Office | 61 | 11 | $3.19 | $195 |
| 99203 Office E&M - New | Office | 38 | 38 | $77.46 | $2,943 |
| 11105 Skin Biopsy | Office | 37 | 24 | $47.10 | $1,743 |
| 36415 Venipuncture Blood Collection | Office | 32 | 21 | $8.40 | $269 |
| 99212 Office E&M - Established | Office | 31 | 20 | $40.61 | $1,259 |
| 11102 Skin Biopsy | Office | 30 | 28 | $60.85 | $1,826 |
| 11104 Skin Biopsy | Office | 26 | 25 | $94.68 | $2,462 |
| 17110 Destruction Skin Lesion | Office | 25 | 19 | $83.44 | $2,086 |
| 99204 Office E&M - New | Office | 24 | 24 | $104.24 | $2,502 |
| 17000 Destruction Skin Lesion | Office | 20 | 18 | $28.09 | $562 |
| 11103 Skin Biopsy | Office | 16 | 13 | $39.59 | $633 |
By year: 2022 $49K for 927 services; 2023 $43K for 899 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 32 | 21 | $8.40 | $269 |
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen J Smith prescribed most often to Medicare patients was Ketoconazole, with 497 prescriptions and refills. In total Kathleen J Smith wrote 3,122 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 497 | 540 | 173 | $8,518 |
| Triamcinolone Acetonide Generic | 386 | 418 | 189 | $4,894 |
| Betamethasone Valerate Generic | 298 | 310 | 146 | $8,133 |
| Clobetasol Propionate Generic | 184 | 196 | 69 | $7,371 |
| Hydrocortisone Generic | 178 | 184 | 92 | $1,126 |
| Mupirocin Generic | 173 | 174 | 154 | $1,216 |
| Tretinoin Generic | 135 | 157 | 65 | $11K |
| Clindamycin Phosphate Generic | 120 | 122 | 57 | $4,809 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 90 | 102 | 37 | $5,162 |
| Doxycycline Monohydrate Generic | 78 | 78 | 36 | $1,583 |
| Finasteride Generic | 74 | 204 | 37 | $954 |
| Spironolactone Generic | 60 | 81 | 22 | $767 |
| Ammonium Lactate Generic | 54 | 60 | 42 | $776 |
| Dupixent Pen Dupilumab | 46 | 46 | Under 11 | $180K |
| Clindamycin Hcl Generic | 44 | 44 | 21 | $810 |
Brand drugs: 617 claims; generic drugs: 2,505 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathleen J Smith $4,700 ($4,700 in general payments such as food, travel and fees) from 17 companies. The largest payer was Novartis Pharmaceuticals Corporation with $2,321.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 20 | $2,321 |
| Genzyme Corporation SNY | 13 | $430 |
| Lilly USA, LLC LLY | 16 | $408 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $333 |
| Pfizer Inc. PFE | 20 | $265 |
| Abbvie Inc. ABBV | 21 | $262 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 8 | $146 |
| LEO Pharma Inc. | 4 | $112 |
| Organon LLC OGN | 6 | $110 |
| Incyte Corporation INCY | 4 | $79.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.